Sharechat Logo

While you were sleeping: Wall St gains on solid earnings

Friday 16th February 2018

Text too small?

Wall Street climbed as investors focused on upbeat corporate earnings such as from Cisco Systems.

In 1.35pm trading in New York, the Dow Jones Industrial Average climbed 0.6 percent, while the Nasdaq Composite Index gained 1 percent. In 1.20pm trading, the Standard & Poor’s 500 Index advanced 0.8 percent.

“The momentum is being fuelled by the realisation that earnings season continues to be the best we’ve had since 2009,” Peter Kenny, senior market strategist at Global Markets Advisory Group, in New York, told Reuters. “We’re going to continue to see some aftershocks in the market, but they will incrementally become less dramatic over time.”

In the latest signs of accelerating inflation, however, a Labour Department report showed US wholesale prices rose in January, with the producer price index increasing 0.4 percent, in line with economists' expectations and following an unchanged reading in December. 

“The drumbeat of higher inflation is getting louder,” Joel Naroff, chief economist at Naroff Economic Advisors in Holland, Pennsylvania, told Reuters. “It does appear as if higher inflation is here to stay.”

US Treasuries were steady, with the yield on the 10-year note at 2.9 percent, close to the highest level in four years. 

“The market is figuring out that 3 percent is digestible on the 10-year yield,” Leo Grohowski, the chief investment officer of BNY Mellon Wealth Management, told Bloomberg. “As long as the reason you’re getting to the 3 percent level is driven by a better feeling about economic growth, which therefore leads to a better feeling about corporate profits. And that’s what I sense taking place.”

Wall Street’s fear gauge—the CBOE Volatility Index or the VIX—rose 2.3 percent to 19.71 as of 1.26pm in New York. The index climbed as high as 50.30 earlier this month. 

The Dow rose as gains in shares of Cisco and those of Apple, recently up 4.4 percent and 3.1 percent respectively, outweighed slides in shares of UnitedHealth and those of Exxon Mobil, recently down 1.9 percent and 0.6 percent respectively.

In Europe, the Stoxx 600 Index finished the day with a 0.5 percent increase from the previous close. Germany’s DAX Index eked out a 0.06 percent gain, the UK’s FTSE 100 index rose 0.3 percent, while France’s CAC40 Index rallied 1.1 percent.

However, shares of Switzerland’s Nestle declined 2.1 percent in Zurich after the consumer goods company reported its weakest sales growth in decades and a drop in profit last year.

The company's organic sales rose by 2.4 per cent in 2017, Nestle said in a statement, while gaining 1.9 percent in the fourth quarter.

"Our 2017 organic sales growth was within the guided range but below our expectations, in particular due to weak sales development towards the end of the year," Mark Schneider, Nestlé CEO, said in a statement. "Sales growth in Europe and Asia was encouraging while North America and Brazil continued to see a challenging environment.”

The company predicted organic sales growth of between 2 percent and 4 percent in 2018, while it forecast underlying trading operating margin improvement in line with its 2020 target.

Having hoped for “optimistic guidance,” Bernstein analyst Andrew Wood said he was left disappointed, Bloomberg reported.

Nestle plans “active portfolio management,” Schneider said. The company does not plan to increase its stake in L'Oreal, it said.

(BusinessDesk)



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors